Clinical Report: Relationship Between TyG Index and Sepsis Risk and Mortality
Overview
This study investigates the association between the triglyceride-glucose (TyG) index and sepsis risk and mortality, highlighting a significant relationship in diabetic individuals. The findings suggest that the TyG index may serve as a useful biomarker for sepsis risk stratification in patients with diabetes.
Background
Sepsis is a critical global health issue, with millions of cases and deaths annually, making it a leading cause of in-hospital mortality. Identifying risk factors for sepsis is essential for prevention and management. The TyG index, a marker of insulin resistance, has shown potential associations with various health outcomes, yet its role in sepsis incidence and mortality, particularly in relation to diabetes status, has not been thoroughly explored.
Data Highlights
Group
Sepsis Incidence HR
Sepsis Mortality HR
Diabetic
1.18 (95% CI: 1.10–1.27)
1.16 (95% CI: 1.05–1.27)
Non-Diabetic
1.02 (95% CI: 0.98–1.06)
0.99 (95% CI: 0.94–1.05)
Key Findings
The TyG index is linearly associated with sepsis incidence and mortality in diabetic individuals.
No significant associations were found between the TyG index and sepsis outcomes in non-diabetic participants.
Each 1-unit increase in the TyG index correlates with an 18% higher risk of sepsis in diabetics.
The TyG index improves predictive performance for sepsis risk models in patients with diabetes.
Sepsis represents a major global health challenge, necessitating effective risk factor identification.
Clinical Implications
Clinicians should consider the TyG index as a potential biomarker for assessing sepsis risk in diabetic patients. This could enhance risk stratification and inform preventive strategies in this vulnerable population.
Conclusion
The study underscores the importance of the TyG index in predicting sepsis outcomes, particularly in diabetic individuals, and highlights the need for further validation in diverse cohorts.
“High-dose intravenous vitamin C administered early after injury did not reduce organ dysfunction or [mortality] and should not be a treatment in severe burns.”
